Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells
about
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinaseHeregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cellsBinding of Neu differentiation factor with the extracellular domain of Her2 and Her3Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferationPhosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell linesCloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transductionEpidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptorsErk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injuryNeural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSPCharacterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampusInteraction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulinMedullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behaviorDirect binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signalingExpression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cellsHeregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3Transmembrane neuregulins interact with LIM kinase 1, a cytoplasmic protein kinase implicated in development of visuospatial cognitionTransformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinaseThe structural basis for the specificity of epidermal growth factor and heregulin bindingDifferential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytesInteractions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomasNeuregulin signaling on glucose transport in muscle cellsTumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4The cellular response to neuregulins is governed by complex interactions of the erbB receptor familyActivation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancerThe relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cellsCsk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferationInduction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase.Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells.Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.Secretion of neu differentiation factor-like polypeptides by cph-transformed fibroblasts: cloning and characterization of Syrian hamster neuregulin cDNAs.Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic dataPrognostic significance of micrometastatic bone marrow involvement.Processing of ARIA and release from isolated nerve terminals.ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.
P2860
Q22009917-8BA566A1-0386-4641-8C16-E05F62C19B7BQ24309266-C71C8D09-25D0-4BCF-A47A-6284700157B1Q24314260-3166012B-892C-4AD9-B604-CBE7BC545159Q24315647-50436ED3-255D-4D2B-BD4C-6282A4319B8AQ24318527-350E875B-AA57-423B-9CFE-4526A34E45BBQ24318725-2C4C798E-300B-45B7-8C46-D0CB3DB172A2Q24336395-6AECF75E-5723-44E8-B879-D232413C41C8Q24532786-F926B3D0-4AB8-40C9-A99A-35BE64313058Q24538180-3F06CE11-794C-4C67-AA6F-1F3CE2F0EBCEQ24563035-66FB3085-4016-4862-B90A-00C8DE805B36Q24563427-F9AFB3F6-7F6C-4E4F-A626-23EC82CA78F1Q24594529-4D1EE610-F339-4EFC-8A89-4A204FA0F458Q24645951-8DFE2AE0-384E-4409-A072-4D593328CF68Q24649294-5485B4B7-471A-4116-8310-9132AAF9BEDBQ24676403-F99C4FD0-EF5B-47A9-A803-23B374EA3280Q28116711-FDE1F0A9-5A0A-47DA-BDE7-6B1660808D02Q28206850-1BC6D122-C6F9-4655-8E62-A5F868EB4A7AQ28215669-EAB47ACE-F79D-4166-8D48-3BF89F3DAACAQ28278050-18403228-B482-490A-9BA3-B84CB762134FQ28279061-14B8C7AA-4974-481C-9FC7-E4A0ADCCA6A3Q28285513-B905BAE7-B430-4196-A3BB-1BA3D1F0CF62Q28300201-88668CC5-B83D-4A60-97B4-3C5661E68949Q28360375-EB94F9D3-B844-4006-BB2F-5393B3A199ADQ28510774-A7946C91-E796-4F40-8B8B-C886C52D1FE1Q28571833-2265AC41-7655-4E82-AE50-B1334802AA49Q28609073-7FBDCCA7-75AB-4CB4-89F4-5D50BFFBE7BAQ28609130-B452E2BC-0016-4396-B2CE-25AFEDA17207Q28609160-19469ED0-F49A-4930-ADF2-DE336764F20AQ28678776-7CB69638-8F18-4627-8A9C-E462E355F7A6Q28678816-DDB61BD6-CCCE-4ADB-BC0F-52AEC25ECF1CQ28678895-E4ED20E9-D3E9-472F-9A1E-583F437E6D36Q30468691-09399FCA-29E4-4B24-AB16-B921A69525BFQ30959633-F1880392-9281-4576-ADD7-2EA587E7C4ACQ31132987-8756B044-3B7F-487E-AF1A-48A241AEE9C1Q32065974-3A4BD1FF-EA4E-492B-83D0-339F52598773Q32068886-B450B732-40B0-4746-9408-664749A02325Q33401214-82D8B011-5E45-40D2-8F2A-3002BE2C958AQ33538449-385CF2D1-D217-49BA-826E-183B794AFF24Q33599024-088B1186-6262-406C-8810-90E292391244Q33781099-68EC91F1-C752-4E2B-9B33-EABB999BA03A
P2860
Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@ast
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en-gb
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@nl
type
label
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@ast
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en-gb
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@nl
prefLabel
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@ast
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en-gb
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@nl
P2093
P1433
P1476
Isolation of the neu/HER-2 sti ...... tiation of mammary tumor cells
@en
P2093
P304
P356
10.1016/0092-8674(92)90131-U
P407
P50
P577
1992-04-03T00:00:00Z